T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	395.93B
Revenue (ttm)	177.27B
Net Income (ttm)	43.76B
Shares Out	8.07M
EPS (ttm)	5,421.80
PE Ratio	9.05
Forward PE	7.46
Dividend	1,500.00 (3.04%)
Ex-Dividend Date	Dec 29, 2025

Volume	22,214
Average Volume	30,373
Open	49,550
Previous Close	49,350
Day's Range	48,700 - 49,550
52-Week Range	43,450 - 85,600
Beta	0.06
RSI	58.50
Earnings Date	Feb 4, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 242
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.